Application of Propofol Target-Controlled Infusion Combined with Etomidate in Painless Gastrointestinal Endoscopy: A Prospective, Randomized Controlled Study

Author:

Luo Huirong1,Zheng Ting2,Chen Andi2,Lin Jingfang2,Ye Peng2,Chen Yingjie2,Lin Mingxue2,Chen Lifei2,Chen Pinzhong2,Chen Xiaohui2,Zheng Xiaochun2

Affiliation:

1. Fujian Medical University Union Hospital

2. Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital

Abstract

Abstract Background Propofol has been widely used in painless gastrointestinal endoscopy; however, it frequently leads to cardiovascular adverse events and respiratory depression. Propofol target-controlled infusion (TCI) can provide safe sedation but may require higher dosages of propofol. On the contrary, etomidate offers hemodynamic stability. This study aimed to investigate the efficacy and safety of propofol TCI combined with etomidate in painless gastrointestinal endoscopy. Methods A total of 330 patients from Fujian Provincial Hospital were randomly divided into three groups: P, 0.1EP, and 0.15EP. Patients in the P group received propofol TCI only, with an initial effect-site concentration of the propofol TCI system of 3.0 µg/mL. Patients in the 0.1EP and 0.15EP groups received 0.1 and 0.15 mg/kg etomidate intravenous injection, respectively, followed by propofol TCI. Results Patients in the 0.15EP group had higher mean blood pressure (MBP) after induction than the other groups (P < 0.05). Propofol consumption significantly decreased in the 0.15EP group compared with that in the other groups (P < 0.05). The induction time was longer in the P group than in the other groups (P < 0.01). The recovery time was shorter in the 0.15EP group than in the other groups (P < 0.01). The incidence of hypotension and injection pain was lower in the 0.15EP group than in the other groups (P < 0.05). Furthermore, the incidence of respiratory depression was lower in the 0.15EP group than in the P group (P < 0.05). Additionally, the satisfaction of the patient, endoscopist, and anesthesiologist was higher in the 0.15EP group than in the other groups (P < 0.05). Conclusions Our findings suggest that 0.15 mg/kg etomidate plus propofol TCI can significantly reduce propofol consumption, which is followed by fewer cardiovascular adverse events and respiratory depression, along with higher patient, endoscopist, and anesthesiologist satisfaction. Thus, this anesthesia strategy is suitable for painless gastrointestinal endoscopy.

Publisher

Research Square Platform LLC

Reference78 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3